Access advanced treatment and research.
At Novant Health Cancer Institute, we're always looking for new ways to detect, prevent and treat cancer. Clinical trials allow us to study new surgical procedures, build upon existing treatments and test new drugs, medical devices and therapies. That means, if eligible to participate in a cancer research trial, you might experience new approaches to treatment while improving cancer care for others in the future.
Novant Health clinical trials
We participate in national and international research designed to improve outcomes and reduce symptoms of cancer, including:
- Early-phase clinical trials for cancer to establish drug safety with novel chemotherapies, immunotherapies and cellular therapies used for treating cancer and other illnesses
- Studies of new imaging technology for cancer and other conditions
- Innovative surgical procedures, such as minimally invasive surgery to shorten recovery times and promote healing
- Pediatric studies for a range of conditions, including cancer, sickle cell disease, hemophilia and other blood disorders
What to expect
Volunteers like you help researchers develop cancer treatments that physicians and specialists rely on in the future. Every drug and device approved for use in the United States has been tested by volunteers in carefully controlled clinical trials.
Novant Health clinical trial research teams are made up of healthcare specialists, including physicians, nurses, study coordinators, data management and regulatory professionals. We partner with Institutional Review Boards to ensure all study volunteers have the information they need to make informed decisions about participating in a clinical cancer trial.
Participation in a research trial is a personal decision. If you want to participate in a clinical trial, speak to your care team. Your specialist will review with you the benefits and possible risks of participating.
Clinical trials are research studies designed to answer specific scientific questions and find effective solutions for preventing, diagnosing or treating a disorder or disease.
The process depends on the type of study being conducted. Trials vary in length. Some studies may last a few weeks; others may last months or years. Our research teams work closely with volunteers so that they understand the required time investments and other aspects of the study before they agree to participate.
When someone chooses to participate in a clinical trial, the medical care they receive during the study is much like the care they would get otherwise. However, there is often additional monitoring to learn about potential side effects and benefits of the therapy being tested. Some trials study new drugs or devices or a combination therapy. Throughout the trial, the volunteer’s physician and the research team monitor the participant closely.
Novant Health clinical research is governed by, and fully compliant with, regulations from the FDA and other regulatory bodies. Furthermore, our clinical research team consists of physicians, nurses, social workers and other healthcare professionals who work to ensure you have a comfortable experience.
Each clinical trial is different, so it is important to ask questions if you are a candidate. We want volunteers to be as well-informed as possible leading up to participation.
Basic pretrial questions include:
- What is this research about?
- How does this research help the treatment of my disorder?
- Why am I an ideal candidate?
- How does participating in this trial benefit me?
- What are the possible risks this research poses to my health?
- How will this trial differ from the treatment I am already receiving?
- What happens at the end of this study?
- How much of my time will this research trial require?
- What happens if I no longer want to participate?
Contact us about clinical research.
Novant Health participates in national and international research to develop innovative ways to prevent, detect and treat health conditions. Clinical trials allow you to receive new medications, therapies or treatments that are not yet available to the general public.